SCHEMBL4482161

SCHEMBL4482161

CN(C)CCC(=O)N(C)c1ccc(NC(=C2C(=O)Nc3cc(F)ccc32)c2cccc(CC(=O)O)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SENP1 Q9P0U3 2/20 0.35
BACE1 P56817 1/20 0.35
FLT3 P36888 4/20 0.33
PDGFRB P09619 2/20 0.32
MEN1 O00255 1/20 0.32
FFAR1 O14842 1/20 0.32
TP53 P04637 1/20 0.32
GLA P06280 1/20 0.32
KMT2A Q03164 1/20 0.32
HPSE Q9Y251 1/20 0.32
EGFR P00533 1/20 0.32
CXCR1 P25024 1/20 0.31
CXCR2 P25025 1/20 0.31
KDR P35968 3/20 0.31
PDGFRA P16234 2/20 0.31
AURKA O14965 1/20 0.31
AURKB Q96GD4 1/20 0.31
AURKC Q9UQB9 1/20 0.31
CYP3A4 P08684 1/20 0.31
FGFR1 P11362 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4482155 1.00 SENP1 (0.35) SENP1BACE1FLT3PDGFRBMEN1
SCHEMBL4485449 0.96 SENP1 (0.35) SENP1BACE1FLT3PDGFRBMEN1
SCHEMBL4485450 0.96 SENP1 (0.35) SENP1BACE1FLT3PDGFRBMEN1
SCHEMBL3527888 0.95 SENP1 (0.34) SENP1BACE1FLT3PDGFRBMEN1
SCHEMBL3527884 0.95 SENP1 (0.34) SENP1BACE1FLT3PDGFRBMEN1
SCHEMBL223753 0.93 BACE1 (0.36) SENP1BACE1FLT3PDGFRBFFAR1
SCHEMBL223754 0.93 BACE1 (0.36) SENP1BACE1FLT3PDGFRBFFAR1
SCHEMBL225304 0.92 SENP1 (0.36) SENP1BACE1FLT3PDGFRBMEN1
SCHEMBL225303 0.92 SENP1 (0.36) SENP1BACE1FLT3PDGFRBMEN1
SCHEMBL3531618 0.92 SENP1 (0.36) SENP1BACE1FLT3PDGFRBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR SENP1 3761/4885BACE1 1615/4885FLT3 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.